Sr. Manager, Scientific Product Management

Sr. Manager, Scientific Product Management

Plasmids are Addgene’s largest and most established product portfolio. They are also the platform from which everything else grows — viral vectors, antibodies, new formats, new markets. The Senior Manager, Scientific Product Management owns day-to-day execution across this portfolio, which includes segmentation, catalog health, roadmap delivery, and launch execution, in close partnership with the Director of Scientific Product Management.

Director, Scientific Product Management

$130, annually + our amazing benefits!

This position will work out of our Watertown, Massachusetts Headquarters with an opportunity to work on a hybrid schedule. Our beautiful office space has free, ample parking with a complimentary shuttle from Harvard Square and is on multiple bus lines, with the cost of public transit covered by Addgene for those onsite at least twice a week.

This is a role for someone who wants to grow a business — who leads with outcomes, moves with urgency, and knows how to translate scientific insight into commercial results. The right candidate will inherit a portfolio with strong foundations and significant untapped potential, and will be expected to deliver on both in the near term while building the strategic runway for 2028 and beyond.

• Track and report on plasmid portfolio performance — including revenue growth, margin optimization, and long-term portfolio health — and deliver on targets set in the Annual Operating Plan (AOP).
• Set and hit clear performance targets for the portfolio: revenue growth, adoption rates, market penetration, and customer retention across academic, biotech, and pharma segments.
• Identify performance gaps and recommend pricing, positioning, promotional, or product‑mix adjustments to protect and grow commercial outcomes.

• Execute the multi‑year plasmid product roadmap, balancing near‑term revenue delivery with longer‑term innovation bets.
• Drive the full product lifecycle for the plasmid portfolio — from opportunity identification and concept validation through launch, growth, optimization, and, where appropriate, rationalization.
• Support the I2L (Idea‑to‑Launch) pipeline for plasmid‑related innovations, including new formats like Transfection‑Ready DNA, defining what comes next on that roadmap, and shepherding line extension projects through gate decisions.
• Apply plasmid segmentation outputs to prioritize where Addgene invests, where it defends, and where it rationalizes — making clear, defensible calls with supporting data.
• Develop and implement a plasmid intake evaluation framework for large deposits, including accept/decline criteria and cost‑benefit analysis, to improve catalog quality and scalability.

• Run an ongoing Voice of the Customer (VOC) program, translating researcher needs into product priorities and roadmap recommendations.
• Maintain deep knowledge of the plasmid competitive landscape — who the players are, what they offer, how Addgene is positioned, and where the gaps and white space lie.
• Monitor market trends, funding shifts, and emerging research applications (e.g., gene therapy, synthetic biology, CRISPR) to anticipate demand and position the portfolio ahead of the curve.
• Turn market intelligence into concrete recommendations, pricing moves, product concepts, or go‑to‑market adjustments.

• Execute annual commercial plans for the plasmid portfolio — launch activities, marketing coordination, channel activation, and partnership initiatives — in partnership with…